Life Sciences And Ariana Pharma Articles & Analysis
20 news found
Sagaert’s CEO appointment follows his successful interim period implementing etherna’s new partnership-driven business strategy. Sagaert joined etherna in 2017 and brings extensive operational and strategic experience in the life sciences industry. Dekkers, who is the founder of investment and advisory firm Novalis Capital Partners LLC and former CEO of Bayer AG and Thermo ...
ByeTheRNA
FREDERICK, Md., March 13, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the fourth quarter ended December 31, 2022, after the close of the financial markets on Thursday, March 16, 2023 and will hold a conference call at ...
FREDERICK, Md., Jan. 25, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announces that TOMI will present its SteraMist brand of products at three upcoming International Society for Pharmaceutical Engineering (ISPE) Conferences in the first quarter of 2023: The ISPE ...
New York, United States—Oct 12, 2022—Managing raw materials as part of the quality system will ensure that all finished healthcare products can meet quality attributes. As a comprehensive supplier of CRO/CMO/CDMO fermentation services, BOC Sciences is able to provide clients with high-standard raw materials to ensure quality attributes of final healthcare products. Some key factors ...
Ariana Pharma, the eXplainable Artificial Intelligence clinical development Company, announced today the presentation of Phase 2 clinical biomarker data from the ANAVEX2-73-PDD-001 Parkinson’s Disease Dementia (PDD) study at the AD/PD 2022 International Conference. MDS-UPDRS Total score improved significantly for patients treated with ANAVEX®2-73 high oral once-daily dose compared to ...
JADBio and BioLizard today announced their partnership. BioLizard is an agile bioinformatics and AI/ML company globally servicing clients in the life sciences, biotechnology and pharmaceutical industries. JADBio is a robust Automated Machine Learning platform that allows intuitive, timely, and interactive creation of ML predictive models on BioMedical and Multi-omics data, while allowing for ...
ByJADBio
Bayer announced a multi-year agreement with Berkeley Lights, Inc. (Nasdaq: BLI) a leader in the functional characterization of live biology, to develop and perform high-throughput functional screening workflows aimed at accelerating and expanding the discovery of novel traits. Terms of the agreement were not disclosed. Berkeley Lights will leverage its platform to screen individual variants of ...
Today, Blue Ocean Robotics the manufacturer of UVD Robots for autonomous UV-C disinfection announced that it was selected by ISS World Services, one of the world’s leading global workplace experience and facility management companies, to provide autonomous robots for disinfection as part of ISS’ global offering. The agreement allows ISS to offer hospital-grade disinfection to its ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine, which has demonstrated at least 10-times (10X) the efficacy compared ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. Mr. Rinderman will focus on managing ...
CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced it has been awarded the International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma, United Kingdom, a ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced that Fundamental Research Corp (“FRC”), one of the world’s largest independent research houses, has launched coverage ...
Canaquest Medical Corp (OTC Markets: “CANQF”) (the “Company” or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to announce its new partnership with the Canadian Cannabis Dispute Resolution Centre (“CCDRC”), a national ...
BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Kate Lewis as President of the company. She joined BIOLIFE4D full time in early 2019 in a market and business development role before being elevated as the first female executive in Company history. Lewis brings more than 25 years of experience and ...
Offer price increased from €39.00 to €43.00 per QIAGEN share in cash Minimum acceptance threshold lowered from 75% to 66.67% of outstanding QIAGEN shares QIAGEN Supervisory and Managing Boards reaffirm unanimous recommendation that QIAGEN shareholders tender all of their QIAGEN shares Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. ...
MedBiome, a company specializing in the development of therapeutics targeting the gut microbiome, today announced that Dr. Shane Climie has been appointed as Vice-President of Business Development. In Dr. Climie’s role as Vice President of Business Development at MedBiome Inc. he is responsible for corporate development, strategy and partnering. Dr. Climie is also President of ...
Third Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, has named seasoned healthcare executive Bill Athenson as its new Chief Executive Officer, the company announced today. David Zapol, Third Pole’s founding CEO, will continue providing strategic counsel to Third Pole. Athenson joins Third Pole building on the ...
KEY FINANCIAL AND OPERATING HIGHLIGHTS1 • Improving Revenue Growth: +4.3% underlying1 (H1 2017: +3.7%) and +4.6% reported • Increased Adjusted Operating Profit: +1.9% underlying1 and +3.3% reported growth to £294.4m (H1 2017: £284.9m), despite higher depreciation and currency headwinds; • Higher Adjusted Diluted Earnings per Share: +2.5% to 24.6p (H1 2017: 24.0p) ...
ByInforma
Leading Energy Efficiency Consultancy EECO2 has delivered over £10 million in global energy savings to the pharmaceutical & life science sector. The energy savings are displayed on their website at www.eeco2.co.uk. The savings delivered to date amount to an astounding 252,217,127kWh and 91,564 Co2 tonnes. EECO2 have firmly established their position as a leading energy consultancy ...
Q1 EBITDA from continuing operations up 14% to € 325 million Life Sciences results driven by ongoing good performance in Nutrition Materials Sciences posts solid results reflecting volume gains and pricing strength EPS € 0.91, 30% higher also due to a lower tax rateMartek integration underway; EBITDA in line with expectations2011 is expected to be a strong year for ...